Jump to content

Breast cancer patients to get access to two additional drugs under universal health program


Recommended Posts

Posted

Breast cancer patients to get access to two additional drugs under universal health program

 

79121698_2579820228752846_6772546943366201344_o.jpg

 

From December 16th, cancer patients will have direct access to two additional cancer treatment drugs under Thailand’s universal health scheme, avoiding the current pay first, refund later scheme.

 

Ms. Wilawan Payanoi, deputy director-general of the Comptroller Department, said today that the department has added Trastuzumab and Ruxolitinib to the OCPA system approved medication list.

 

Trastuzumab is used in the initial treatment of breast cancer when cancerous cells are multiplying rapidly, whereas Ruxolitinib is for patients suffering from Myelofibrosis, a cancer of the bone marrow.

 

Doctors who need the two drugs to treat their patients under the universal health scheme must register to get access to them.

 

Source: https://www.thaipbsworld.com/breast-cancer-patients-to-get-access-to-two-additional-drugs-under-universal-health-program/

 

thaipbs.jpg

-- © Copyright Thai PBS 2019-12-10
  • Like 2

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...